𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia

✍ Scribed by David O’Connor; Keith Sibson; Mark Caswell; Philip Connor; Michelle Cummins; Chris Mitchell; Jayashree Motwani; Mary Taj; Ajay Vora; Robert Wynn; Pamela R. Kearns

Book ID
108677330
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
66 KB
Volume
154
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clofarabine and high-dose cytosine arabi
Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
✍ Eric Tse; Anskar Y. H. Leung; Joycelyn Sim; Harold K. K. Lee; Herman S. Y. Liu; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 98 KB

Clofarabine (40 mg/m^2^/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2 g/m^2^/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (__N__ = 4) and relapsed (__N__ = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myel

The use of higher dose clofarabine in ad
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia
✍ Bradley A. McGregor; Alexander W. Brown; Michael B. Osswald; Michael R. Savona 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

## Abstract The standard dose of clofarabine is 52 mg/m^2^ for pediatrics and 40 mg/m^2^ in adults. Clofarabine dosed at 52 mg/m^2^ was used in adult patients with refractory ALL to maximize response before allo‐HSCT. All patients had a significant response to therapy. Published pharmacokinetic ana

Clofarabine in the treatment of poor ris
Clofarabine in the treatment of poor risk acute myeloid leukaemia
✍ Janusz Krawczyk; Naeem Ansar; Ronan Swords; Tracy Murphy; Barry MacDonagh; Teres 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract Clofarabine is a second generation nucleoside analogue. It inhibits DNA repair and activates the mitochondrial apoptotic pathway leading to cell death. __In vitro__ clofarabine has demonstrated synergy with daunorubicin and Ara‐C and in phase II clinical trials has shown promising activ

Hepatotoxicity in the treatment of acute
Hepatotoxicity in the treatment of acute lymphoblastic leukaemia
✍ Topley, J. M. ;Benson, J. ;Squier, M. V. ;Chessells, J. M. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

Serial liver function tests and percutaneous liver biopsies were performed on 21 children receiving treatment for acute lymphoblastic leukaemia (ALL). The patients received continuing chemotherapy either with daily 6-mercaptopurine and weekly methotrexate or with five-day pulses of these drugs every